Global Brain Tumor Diagnosis and Treatment Market Size Study, by Product Type (Primary Brain Tumor, Secondary Brain Tumor), by Product Analysis (Stains & Varnishes, Shellacs, Lacquers, Others), by Diagnosis Type (CT Scan, MRI, PET-CT Scan, Molecular Testi

Global Brain Tumor Diagnosis and Treatment Market Size Study, by Product Type (Primary Brain Tumor, Secondary Brain Tumor), by Product Analysis (Stains & Varnishes, Shellacs, Lacquers, Others), by Diagnosis Type (CT Scan, MRI, PET-CT Scan, Molecular Testing, EEG, Others), by Treatment Type (Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy), by End User (Hospitals, Ambulatory Surgical Centers) and Regional Forecasts 2022-2032


The Global Brain Tumor Diagnosis and Treatment Market is currently valued at approximately USD 0.57 billion in 2023 and is projected to expand at a robust compound annual growth rate (CAGR) of 7.82% during the forecast period from 2024 to 2032. Brain tumors, characterized by abnormal cell growth within the brain, pose significant diagnostic and therapeutic challenges. The market for diagnosing and treating brain tumors is being revolutionized by technological advancements and enhanced precision tools. These innovations have enabled healthcare professionals to detect tumors at an earlier stage, refine treatment protocols, and improve patient outcomes.

The remarkable growth in this market is driven by rising incidence rates of brain tumors, coupled with increasing awareness of the latest diagnostic and treatment methods. Advanced imaging techniques such as MRI and PET-CT scans have become the cornerstone of accurate diagnoses, providing detailed insights into tumor size, location, and malignancy. Simultaneously, treatment modalities like immunotherapy and targeted therapy are rapidly gaining traction, offering personalized solutions that minimize side effects and improve survival rates.

Moreover, substantial investments in healthcare infrastructure and research have amplified the availability of sophisticated diagnostic tools and therapeutic options. Government initiatives and funding for cancer research are bolstering this market, enabling the development of innovative technologies and expanding access to cutting-edge treatments. However, challenges such as the high cost of advanced diagnostic equipment and treatment procedures may hinder market growth. Additionally, the complex nature of brain tumor pathophysiology necessitates a multidisciplinary approach, adding to the intricacies of management.

Regionally, North America dominates the market, driven by well-established healthcare infrastructure, high investment in cancer research, and a strong presence of key industry players. Europe follows closely, with robust R&D activities and growing adoption of advanced diagnostic and treatment solutions. Meanwhile, the Asia-Pacific region is anticipated to witness the fastest growth rate due to increasing healthcare spending, rising awareness about early diagnosis, and improving access to advanced medical technologies.

Major market players included in this report are:
• Roche Diagnostics
• Siemens Healthineers
• General Electric (GE) Healthcare
• Canon Medical Systems Corporation
• Medtronic plc
• Elekta AB
• Varian Medical Systems, Inc.
• Pfizer Inc.
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc.
• Amgen Inc.
• Novartis AG
• AbbVie Inc.
• Philips Healthcare
• Bayer AG

The detailed segments and sub-segment of the market are explained below:

By Product Type:
• Primary Brain Tumor
• Secondary Brain Tumor

By Product Analysis:
• Stains & Varnishes
• Shellacs
• Lacquers
• Others

By Diagnosis Type:
• CT Scan
• MRI
• PET-CT Scan
• Molecular Testing
• EEG
• Others

By Treatment Type:
• Surgery
• Radiation Therapy
• Targeted Therapy
• Chemotherapy
• Immunotherapy

By End User:
• Hospitals
• Ambulatory Surgical Centers

By Region:

North America:
• U.S.
• Canada

Europe:
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific:
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America:
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa:
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand-side and supply-side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.


Chapter 1. Global Brain Tumor Diagnosis and Treatment Market Executive Summary
1.1. Global Brain Tumor Diagnosis and Treatment Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product Type
1.3.2. By Product Analysis
1.3.3. By Diagnosis Type
1.3.4. By Treatment Type
1.3.5. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Brain Tumor Diagnosis and Treatment Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Brain Tumor Diagnosis and Treatment Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Incidence of Brain Tumors
3.1.2. Advancements in Diagnostic Technologies
3.1.3. Rising Investments in Healthcare Infrastructure
3.2. Market Challenges
3.2.1. High Cost of Advanced Diagnostic Equipment
3.2.2. Complexity of Brain Tumor Pathophysiology
3.3. Market Opportunities
3.3.1. Expansion of Personalized Medicine
3.3.2. Innovations in Treatment Modalities
3.3.3. Government Initiatives and Funding
Chapter 4. Global Brain Tumor Diagnosis and Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Brain Tumor Diagnosis and Treatment Market Size & Forecasts by Product Type 2022-2032
5.1. Segment Dashboard
5.2. Global Brain Tumor Diagnosis and Treatment Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
5.2.1. Primary Brain Tumor
5.2.2. Secondary Brain Tumor
Chapter 6. Global Brain Tumor Diagnosis and Treatment Market Size & Forecasts by Product Analysis 2022-2032
6.1. Segment Dashboard
6.2. Global Brain Tumor Diagnosis and Treatment Market: Product Analysis Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
6.2.1. Stains & Varnishes
6.2.2. Shellacs
6.2.3. Lacquers
6.2.4. Others
Chapter 7. Global Brain Tumor Diagnosis and Treatment Market Size & Forecasts by Diagnosis Type 2022-2032
7.1. Segment Dashboard
7.2. Global Brain Tumor Diagnosis and Treatment Market: Diagnosis Type Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
7.2.1. CT Scan
7.2.2. MRI
7.2.3. PET-CT Scan
7.2.4. Molecular Testing
7.2.5. EEG
7.2.6. Others
Chapter 8. Global Brain Tumor Diagnosis and Treatment Market Size & Forecasts by Treatment Type 2022-2032
8.1. Segment Dashboard
8.2. Global Brain Tumor Diagnosis and Treatment Market: Treatment Type Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
8.2.1. Surgery
8.2.2. Radiation Therapy
8.2.3. Targeted Therapy
8.2.4. Chemotherapy
8.2.5. Immunotherapy
Chapter 9. Global Brain Tumor Diagnosis and Treatment Market Size & Forecasts by End User 2022-2032
9.1. Segment Dashboard
9.2. Global Brain Tumor Diagnosis and Treatment Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
9.2.1. Hospitals
9.2.2. Ambulatory Surgical Centers
Chapter 10. Global Brain Tumor Diagnosis and Treatment Market Size & Forecasts by Region 2022-2032
10.1. North America Brain Tumor Diagnosis and Treatment Market
10.1.1. U.S. Brain Tumor Diagnosis and Treatment Market
10.1.1.1. Product Type Breakdown Size & Forecasts, 2022-2032
10.1.1.2. Product Analysis Breakdown Size & Forecasts, 2022-2032
10.1.2. Canada Brain Tumor Diagnosis and Treatment Market
10.2. Europe Brain Tumor Diagnosis and Treatment Market
10.2.1. UK Brain Tumor Diagnosis and Treatment Market
10.2.2. Germany Brain Tumor Diagnosis and Treatment Market
10.2.3. France Brain Tumor Diagnosis and Treatment Market
10.2.4. Spain Brain Tumor Diagnosis and Treatment Market
10.2.5. Italy Brain Tumor Diagnosis and Treatment Market
10.2.6. Rest of Europe Brain Tumor Diagnosis and Treatment Market
10.3. Asia-Pacific Brain Tumor Diagnosis and Treatment Market
10.3.1. China Brain Tumor Diagnosis and Treatment Market
10.3.2. India Brain Tumor Diagnosis and Treatment Market
10.3.3. Japan Brain Tumor Diagnosis and Treatment Market
10.3.4. Australia Brain Tumor Diagnosis and Treatment Market
10.3.5. South Korea Brain Tumor Diagnosis and Treatment Market
10.3.6. Rest of Asia-Pacific Brain Tumor Diagnosis and Treatment Market
10.4. Latin America Brain Tumor Diagnosis and Treatment Market
10.4.1. Brazil Brain Tumor Diagnosis and Treatment Market
10.4.2. Mexico Brain Tumor Diagnosis and Treatment Market
10.4.3. Rest of Latin America Brain Tumor Diagnosis and Treatment Market
10.5. Middle East & Africa Brain Tumor Diagnosis and Treatment Market
10.5.1. Saudi Arabia Brain Tumor Diagnosis and Treatment Market
10.5.2. South Africa Brain Tumor Diagnosis and Treatment Market
10.5.3. Rest of Middle East & Africa Brain Tumor Diagnosis and Treatment Market
Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
11.1.1. Roche Diagnostics
11.1.2. Siemens Healthineers
11.1.3. General Electric (GE) Healthcare
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Roche Diagnostics
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Market Strategies
11.3.2. Medtronic plc
11.3.3. Elekta AB
11.3.4. Varian Medical Systems, Inc.
11.3.5. Pfizer Inc.
11.3.6. Johnson & Johnson Services, Inc.
11.3.7. Merck & Co., Inc.
11.3.8. Amgen Inc.
11.3.9. Novartis AG
11.3.10. AbbVie Inc.
11.3.11. Philips Healthcare
11.3.12. Bayer AG
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
List of Tables
TABLE 1. Global Brain Tumor Diagnosis and Treatment Market, Report Scope
TABLE 2. Global Brain Tumor Diagnosis and Treatment Market Estimates & Forecasts by Region 2022-2032 (USD Million/Billion)
TABLE 3. Global Brain Tumor Diagnosis and Treatment Market Estimates & Forecasts by Product Type 2022-2032 (USD Million/Billion)
TABLE 4. Global Brain Tumor Diagnosis and Treatment Market Estimates & Forecasts by Product Analysis 2022-2032 (USD Million/Billion)
TABLE 5. Global Brain Tumor Diagnosis and Treatment Market Estimates & Forecasts by Diagnosis Type 2022-2032 (USD Million/Billion)
TABLE 6. Global Brain Tumor Diagnosis and Treatment Market Estimates & Forecasts by Treatment Type 2022-2032 (USD Million/Billion)
TABLE 7. Global Brain Tumor Diagnosis and Treatment Market Estimates & Forecasts by End User 2022-2032 (USD Million/Billion)
TABLE 8. Global Brain Tumor Diagnosis and Treatment Market Estimates & Forecasts by Product Type 2022-2032 (USD Million/Billion)
TABLE 9. Global Brain Tumor Diagnosis and Treatment Market Estimates & Forecasts by Product Analysis 2022-2032 (USD Million/Billion)
TABLE 10. Global Brain Tumor Diagnosis and Treatment Market Estimates & Forecasts by Diagnosis Type 2022-2032 (USD Million/Billion)
TABLE 11. Global Brain Tumor Diagnosis and Treatment Market Estimates & Forecasts by Treatment Type 2022-2032 (USD Million/Billion)
TABLE 12. Global Brain Tumor Diagnosis and Treatment Market Estimates & Forecasts by End User 2022-2032 (USD Million/Billion)
TABLE 13. U.S. Brain Tumor Diagnosis and Treatment Market Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 14. U.S. Brain Tumor Diagnosis and Treatment Market Estimates & Forecasts by Product Type 2022-2032 (USD Million/Billion)
TABLE 15. U.S. Brain Tumor Diagnosis and Treatment Market Estimates & Forecasts by Product Analysis 2022-2032 (USD Million/Billion)
TABLE 16. U.S. Brain Tumor Diagnosis and Treatment Market Estimates & Forecasts by Diagnosis Type 2022-2032 (USD Million/Billion)
TABLE 17. U.S. Brain Tumor Diagnosis and Treatment Market Estimates & Forecasts by Treatment Type 2022-2032 (USD Million/Billion)
TABLE 18. Canada Brain Tumor Diagnosis and Treatment Market Estimates & Forecasts 2022-2032 (USD Million/Billion)
TABLE 19. Canada Brain Tumor Diagnosis and Treatment Market Estimates & Forecasts by Product Type 2022-2032 (USD Million/Billion)
TABLE 20. Canada Brain Tumor Diagnosis and Treatment Market Estimates & Forecasts by Product Analysis 2022-2032 (USD Million/Billion)
This list is not complete; the final report does contain more than 100 tables. The list may be updated in the final deliverable.
List of Figures
FIGURE 1. Global Brain Tumor Diagnosis and Treatment Market, Research Methodology
FIGURE 2. Global Brain Tumor Diagnosis and Treatment Market, Market Estimation Techniques
FIGURE 3. Global Market Size Estimates & Forecast Methods
FIGURE 4. Global Brain Tumor Diagnosis and Treatment Market, Key Trends 2023
FIGURE 5. Global Brain Tumor Diagnosis and Treatment Market, Growth Prospects 2022-2032
FIGURE 6. Global Brain Tumor Diagnosis and Treatment Market, Porter’s 5 Force Model
FIGURE 7. Global Brain Tumor Diagnosis and Treatment Market, PESTEL Analysis
FIGURE 8. Global Brain Tumor Diagnosis and Treatment Market, Value Chain Analysis
FIGURE 9. Global Brain Tumor Diagnosis and Treatment Market by Segment, 2022 & 2032 (USD Million/Billion)
FIGURE 10. Global Brain Tumor Diagnosis and Treatment Market by Segment, 2022 & 2032 (USD Million/Billion)
FIGURE 11. Global Brain Tumor Diagnosis and Treatment Market by Segment, 2022 & 2032 (USD Million/Billion)
FIGURE 12. Global Brain Tumor Diagnosis and Treatment Market by Segment, 2022 & 2032 (USD Million/Billion)
FIGURE 13. Global Brain Tumor Diagnosis and Treatment Market by Segment, 2022 & 2032 (USD Million/Billion)
FIGURE 14. Global Brain Tumor Diagnosis and Treatment Market, Regional Snapshot 2022 & 2032
FIGURE 15. North America Brain Tumor Diagnosis and Treatment Market 2022 & 2032 (USD Million/Billion)
FIGURE 16. Europe Brain Tumor Diagnosis and Treatment Market 2022 & 2032 (USD Million/Billion)
FIGURE 17. Asia-Pacific Brain Tumor Diagnosis and Treatment Market 2022 & 2032 (USD Million/Billion)
FIGURE 18. Latin America Brain Tumor Diagnosis and Treatment Market 2022 & 2032 (USD Million/Billion)
FIGURE 19. Middle East & Africa Brain Tumor Diagnosis and Treatment Market 2022 & 2032 (USD Million/Billion)
FIGURE 20. Global Brain Tumor Diagnosis and Treatment Market, Company Market Share Analysis (2023)
This list is not complete; the final report does contain more than 50 figures. The list may be updated in the final deliverable.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings